Published in Int J Gynecol Pathol on October 01, 1997
Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway. Mol Cancer (2009) 1.09
The genomics and genetics of endometrial cancer. Adv Genomics Genet (2012) 1.03
KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer. Br J Cancer (2012) 0.87
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature (1987) 2.98
Impact of dosage frequency on patient compliance. Diabetes Care (1997) 2.43
A region of the Herpesvirus saimiri genome required for oncogenicity. Science (1985) 2.22
Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med (1995) 2.13
Validation of clinical problems using a UMLS-based semantic parser. Proc AMIA Symp (1998) 1.91
Construction of replication-competent Herpesvirus saimiri deletion mutants. J Virol (1984) 1.89
A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. J Virol (1996) 1.84
Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health (1992) 1.81
An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun (1999) 1.75
Conditional identification of phosphate-starvation-response mutants in Arabidopsis thaliana. Planta (2000) 1.68
Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type. Cancer (1993) 1.66
Absence of jaagsiekte sheep retrovirus DNA and RNA in bronchioloalveolar and conventional human pulmonary adenocarcinoma by PCR and RT-PCR analysis. Hum Pathol (2001) 1.66
Sex differences in the pharmacological treatment of hypertension: a review of population-based studies. J Hypertens (1997) 1.62
Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R. Arterioscler Thromb Vasc Biol (1998) 1.59
Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab Dispos (2000) 1.56
Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol (1992) 1.55
Molecular cloning of Lyt-2, a membrane glycoprotein marking a subset of mouse T lymphocytes: molecular homology to its human counterpart, Leu-2/T8, and to immunoglobulin variable regions. Proc Natl Acad Sci U S A (1985) 1.53
Peptides which bind to E-selectin and block neutrophil adhesion. J Biol Chem (1995) 1.48
Improving morning care routines of nursing home residents with dementia. J Am Geriatr Soc (1999) 1.48
A gene for dihydrofolate reductase in a herpesvirus. Science (1988) 1.47
Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity. Arterioscler Thromb Vasc Biol (1999) 1.47
Non-puerperal lactation associated with antidepressant drug use. Br J Clin Pharmacol (1997) 1.46
Cation/proton antiport systems in Escherichia coli. Solubilization and reconstitution of delta pH-driven sodium/proton and calcium/proton antiporters. J Biol Chem (1986) 1.46
Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort. Cancer Res (2001) 1.45
Characterization of two classes of ribonucleoprotein complexes possibly involved in RNA editing from Leishmania tarentolae mitochondria. EMBO J (1994) 1.36
Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations. J Biol Chem (1994) 1.33
Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab (1994) 1.28
Escherichia coli K-12 cell-cell interactions seen by time-lapse video. J Bacteriol (1989) 1.28
Differential growth kinetics are exhibited by human immunodeficiency virus type 1 TAR mutants. J Virol (1994) 1.27
Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells. J Exp Med (2001) 1.26
The origin and molecular characterization of adenoid basal carcinoma of the uterine cervix. Int J Gynecol Pathol (1997) 1.24
Efficacy of fine needle aspiration cytology in the diagnosis of tuberculous cervical lymphadenopathy. J Laryngol Otol (1990) 1.23
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma. Br J Cancer (2010) 1.22
Cardiovascular diseases and risk factors in a population-based study in The Netherlands: agreement between questionnaire information and medical records. Neth J Med (1999) 1.22
Smoking, passive smoking and histological types in lung cancer in Hong Kong Chinese women. Br J Cancer (1987) 1.21
Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components. Hum Pathol (1998) 1.18
Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo. J Virol (1997) 1.17
Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivity. Gene Ther (2009) 1.17
The impact of adjuvant radiotherapy on carcinosarcoma of the uterus. Gynecol Oncol (1998) 1.15
Mapping of RNA transcribed from a region of the Herpesvirus saimiri genome required for oncogenicity. J Virol (1984) 1.14
T-DNA organization in homogeneous and heterogeneous octopine-type crown gall tissues of Nicotiana tabacum. Cell (1982) 1.14
NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med (1998) 1.14
A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody. J Pharm Sci (2001) 1.12
Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma. Br J Cancer (2012) 1.11
Increased expression of keratinocyte growth factor messenger RNA associated with inflammatory bowel disease. Gastroenterology (1996) 1.11
Scenario analysis of the future of medicines. BMJ (1994) 1.11
Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis. Arch Surg (1993) 1.10
The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood. Cancer Res (1997) 1.10
Information on drug use in the elderly: a comparison of pharmacy, general-practitioner and patient data. Pharm World Sci (1995) 1.10
Influence of question structure on the recall of self-reported drug use. J Clin Epidemiol (2000) 1.10
Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics (1992) 1.10
Current use of thiazide diuretics and prevention of femur fractures. J Clin Epidemiol (1996) 1.09
Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies. Leukemia (2007) 1.09
p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma. Cancer (1998) 1.08
Antibacterial substances from staphylococci. Can J Microbiol (1967) 1.08
Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature. Mod Pathol (2000) 1.07
Molecular genotyping of BK and JC viruses in human polyomavirus-associated interstitial nephritis after renal transplantation. Am J Kidney Dis (2001) 1.07
Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas. Mod Pathol (1999) 1.06
Usage patterns of benzodiazepines in a Dutch community: a 10-year follow-up. Pharm World Sci (1998) 1.06
Immunization against endogenous retroviral tumor-associated antigens. Cancer Res (2001) 1.05
Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in The Netherlands. Pharm World Sci (1999) 1.05
Glutathione S-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the Central and Eastern European Kidney Cancer Study. Carcinogenesis (2007) 1.05
Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues. Anal Biochem (1997) 1.04
Polypyrimidine tract-binding protein and heterogeneous nuclear ribonucleoprotein A1 bind to human T-cell leukemia virus type 2 RNA regulatory elements. J Virol (1995) 1.03
Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology. Biosci Rep (2005) 1.03
Heterogeneity of intraductal carcinoma of the breast. Cancer (1989) 1.02
Specific binding of polypyrimidine tract binding protein and hnRNP A1 to HIV-1 CRS elements. Virus Genes (1996) 1.02
Existence of mature human CD4+ T cells with genuine class I restriction. Eur J Immunol (1992) 1.02
Pathogenesis of acute myocardial necrosis in inbred mice infected with coxsackievirus B3. Microb Pathog (1988) 1.01
Regional cerebral blood flow in humans at high altitude: gradual ascent and 2 wk at 5,050 m. J Appl Physiol (1985) (2013) 1.01
Synthesis of bovine growth hormone in primates by using a herpesvirus vector. Mol Cell Biol (1985) 1.00
A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments. J Nerv Ment Dis (1997) 1.00
Therapeutic potential for adenosine receptor activation in ischemic brain injury. J Neurotrauma (1992) 0.99
K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients. Cancer Res (1997) 0.99
Clinical risk factors for pulmonary barotrauma: a multivariate analysis. Am J Respir Crit Care Med (1995) 0.99
Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study. Curr Med Res Opin (2008) 0.98
K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients. Cancer Lett (1997) 0.98
Fibreoptic bronchoscopy in the diagnosis of bronchial cancer: comparison of washings, brushings and biopsies in central and peripheral tumours. Clin Oncol (1983) 0.98
Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2. Lab Invest (1997) 0.98
Generation of T cells specific for the wild-type sequence p53(264-272) peptide in cancer patients: implications for immunoselection of epitope loss variants. J Immunol (2000) 0.97
[Pharmaco-morbidity linking: a pilot study of its technical possibilities in The Netherlands]. Ned Tijdschr Geneeskd (1990) 0.97